Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 52.28% | 31.00% | 29.22% | 16.98% | 6.03% |
| Total Depreciation and Amortization | -78.54% | -91.53% | -60.00% | -34.18% | -10.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 144.44% | -71.43% | -85.71% | -251.28% | -77.50% |
| Change in Net Operating Assets | -43.50% | 2.71% | -5.41% | -2.07% | -8.61% |
| Cash from Operations | 142.42% | 241.67% | 225.45% | 551.52% | -189.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 13.83% | 1.14% | -37.91% | -23.36% | 4.04% |
| Total Debt Repaid | -151.49% | -59.76% | 44.09% | 0.20% | 67.32% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -169.23% | -174.68% | 94.44% | -444.44% | 154.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -196.88% | 514.29% | 192.47% | 198.08% | 138.55% |